Prescription drug · NDA
Verapamil Hci NDC 51662-1442
Verapamil hydrochloride 2.5 mg/mL · Injection · Intravenous · HF Acquisition Co LLC, DBA HealthFirst
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51662-1442-1 | 51662144201 | 2 mL in 1 VIAL (51662-1442-1)Marketed from Dec 22, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Verapamil Hci
- Generic name (nonproprietary)
- verapamil hci
- Active ingredients
- Verapamil hydrochloride — 2.5 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018925
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
- Identifiers
- Product ID 51662-1442_12506f53-54b9-53d1-e063-6294a90addc5SPL ID 12506f53-54b9-53d1-e063-6294a90addc5SPL set ID 9a4f12ec-fe1c-a1b9-e053-2a95a90ac8e4RxCUI 1665057UNII V3888OEY5R
- Pharmacologic class
- Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N451662144201followed by a unit qualifier and the quantityPackage 51662-1442-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS & USAGE Verapamil is indicated for the treatment of supraventricular tachyarrhythmias, including: • Rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White [WPW] and Lown-Ganong-Levine [LGL] syndromes). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver) should be attempted prior to Verapamil administration. • Temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation, except when the atrial flutter and/or atrial fibrillation are associated with accessory bypass tracts (Wolff-Parkinson-White [WPW] and Lown-Ganong-Levine [LGL] …
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 018925
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | InjectionIntravenous | EXELA PHARMA SCIENCES, LLC | 51754-0204 |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | InjectionIntravenous | EXELA PHARMA SCIENCES, LLC | 51754-0203 |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | InjectionIntravenous | Medical Purchasing Solutions, LLC | 71872-7048 |